Debut Plus

2,859.8

-62.24 -2.13%

18 Jul 2026

NSE Listed · Pharmaceuticals

RPG Life Sciences Ltd. (RPGLIFE)

Volume: 1,306Avg Vol 1W: 11,195Avg Vol 1M: 31,86252W Range:1,7332,993.8
Market Cap₹4,730 Cr
Current Price₹2,859.8
Previous Close₹2,922.04
High / Low (52w)₹2,993.8 / ₹1,733
Volume1,306
Avg Vol (1W)11,195
Avg Vol (1M)31,862
Stock P/E158.17
Book Value₹366.01
Dividend Yield84%
ROE19.03%
ROA14.52%
Revenue (TTM)
Revenue Growth
Profit Margin16.28%
Total Debt₹20 Cr
Shares Outstanding2 Cr
Face Value₹8
EPS (TTM)₹66.31
P/B7.81
Debt / Equity0.02
50 DMA₹2,470.3
200 DMA₹2,153.31
Day change-2.13%
Price Chart
2,859.8 27.10% · 1Y
2978173416.8L
2025-11-24
2026-07-17

20-day avg volume: 35K shares

Pros
  • Healthy return on equity of 19.0%.
  • Pays a dividend yield of 84.0%.
  • Company is almost debt-free.
  • Revenue grew 10% YoY.
Cons
  • Stock trades at a high P/E of 158.
Quarterly Results
MetricMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Sept 2025Dec 2025Mar 2026
Revenue₹127 Cr₹165 Cr₹172 Cr₹173 Cr₹143 Cr₹182 Cr₹180 Cr₹177 Cr
EBITDA₹18 Cr₹36 Cr₹43 Cr₹47 Cr₹25 Cr₹38 Cr₹38 Cr₹39 Cr
Net Profit₹13 Cr₹27 Cr₹4 Cr₹35 Cr₹117 Cr₹37 Cr₹22 Cr₹30 Cr
EPS8.0116.182.54
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹376 Cr₹390 Cr₹443 Cr₹518 Cr₹589 Cr₹666 Cr₹733 Cr
EBITDA₹44 Cr₹54 Cr₹74 Cr₹92 Cr₹118 Cr₹151 Cr₹151 Cr
Net Profit₹29 Cr₹40 Cr₹51 Cr₹68 Cr₹88 Cr₹183 Cr₹115 Cr
EPS17.5424.1931.1340.953.01110.869.64
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹267 Cr₹303 Cr₹345 Cr₹419 Cr₹513 Cr₹658 Cr₹793 Cr
Total Liabilities₹90 Cr₹87 Cr₹89 Cr₹112 Cr₹138 Cr₹127 Cr₹188 Cr
Equity₹177 Cr₹216 Cr₹256 Cr₹308 Cr₹375 Cr₹531 Cr₹605 Cr
Total Debt₹2 Cr₹1 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹67 Cr₹84 Cr₹116 Cr₹124 Cr₹131 Cr₹94 Cr
Investing₹-8 Cr₹-35 Cr₹-106 Cr₹-79 Cr₹-42 Cr₹86 Cr
Financing₹-10 Cr₹-14 Cr₹-17 Cr₹-20 Cr₹-27 Cr₹-21 Cr
Free Cash Flow₹67 Cr₹84 Cr₹116 Cr₹124 Cr₹131 Cr₹94 Cr
Shareholding
Promoter 72.95% Institutions 8.32% Public 18.73%
Efficiency & Working Capital
ROCE24.7%
Interest Coverage88.1
Dividend Payout
Debtor Days60 d
Inventory Days64 d
Payable Days50 d
Cash Conversion Cycle74 d
Working Capital Days124 d
Shareholding Details

As of 2026-03-31

Promoter73%
FII0.9%
DII7.4%
Institutions8.3%
Public18.7%
Promoter Pledge0%
No. of Shareholders25,282
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters72.8%72.8%72.8%72.8%72.8%72.8%73%73%73%73%73%73%
FIIs0.3%0.5%0.6%0.9%1.1%1.3%1.3%1.5%1.3%1.1%1%0.9%
DIIs2.3%3.6%3.8%4.2%4.6%5.5%6.1%6.1%6.5%6.7%7%7.4%
Public24.6%23.1%22.8%22.1%21.4%20.4%19.7%19.5%19.2%19.2%19%18.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders20,22621,08821,86622,13722,23223,48124,89124,86725,83226,65725,90525,282
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Nucleus Life Trust (mr. Harsh Vardhan Goenka Is A Trustee)Shareholding of Promoter and Promoter Group53.9%89,20,831
Ektara Enterprises LlpShareholding of Promoter and Promoter Group15.6%25,75,494
Clarus Capital IPublic Shareholding4.4%7,33,647
Stel Holdings LimitedShareholding of Promoter and Promoter Group3.2%5,25,369
Authum Investment And Infrastructure LimitedPublic Shareholding2%3,33,474
Harshvardhan GoenkaShareholding of Promoter and Promoter Group0.2%26,915
Mala GoenkaShareholding of Promoter and Promoter Group0.1%8,747
Carniwal Investments LimitedShareholding of Promoter and Promoter Group0%6,500
Instant Holdings LimitedShareholding of Promoter and Promoter Group0%598
Summit Securities LimitedShareholding of Promoter and Promoter Group0%398
Chattarpati Apartments LlpShareholding of Promoter and Promoter Group0%362
Atlantus Dwellings And Infrastructure LlpShareholding of Promoter and Promoter Group0%10
Malabar Coastal Holdings LlpShareholding of Promoter and Promoter Group0%10
Sofreal Mercantrade Pvt LtdShareholding of Promoter and Promoter Group0%10
Swallow Associates LlpShareholding of Promoter and Promoter Group0%10
Vayu Associates LlpShareholding of Promoter and Promoter Group0%10
Citibank N A Jt Ac Sakina Asgarali Morbiwala Nooruddin A MorbiwalaPublic Shareholding0%150
Rg Family Trust (mr. Anant Vardhan Goenka Is A Trustee)Shareholding of Promoter and Promoter Group0%10
Ishaan Goenka Trust (mr. Harsh Vardhan Goenka Is A Trustee)Shareholding of Promoter and Promoter Group0%10
Navya Goenka Trust (mr. Harsh Vardhan Goenka Is A Trustee)Shareholding of Promoter and Promoter Group0%10
Secura India Trust (mr. Harsh Vardhan Goenka Is A Trustee )Shareholding of Promoter and Promoter Group0%2
Avg Family Trust (mr. Anant Vardhan Goenka Is Atrustee )Shareholding of Promoter and Promoter Group0%10
Prism Estates Trust (mr. Harsh Vardhan Goenka Is A Trustee )Shareholding of Promoter and Promoter Group0%1
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Harshvardhan Goenka00%2026-03-31
Mala Goenka00%2026-03-31
Nucleus Life Trust (mr. Harsh Vardhan Goenka Is A Trustee)00%2026-03-31
Rg Family Trust (mr. Anant Vardhan Goenka Is A Trustee)00%2026-03-31
Ishaan Goenka Trust (mr. Harsh Vardhan Goenka Is A Trustee)00%2026-03-31
Navya Goenka Trust (mr. Harsh Vardhan Goenka Is A Trustee)00%2026-03-31
Secura India Trust (mr. Harsh Vardhan Goenka Is A Trustee )00%2026-03-31
Avg Family Trust (mr. Anant Vardhan Goenka Is Atrustee )00%2026-03-31
Prism Estates Trust (mr. Harsh Vardhan Goenka Is A Trustee )00%2026-03-31
Ektara Enterprises Llp00%2026-03-31
Stel Holdings Limited00%2026-03-31
Carniwal Investments Limited00%2026-03-31
Board of Directors
NameDesignationYear
H V GoenkaChairman & Non Executive Dir.2026
Manoj K MaheshwariNon-Exec & Non-Independent Dir2026
Zahabiya Habil KhorakiwalaIndependent Non Exe. Director2026
Bhaskar Vemban IyerIndependent Non Exe. Director2026
Sachin NandgaonkarIndependent Non Exe. Director2026
Rajat BhargavaNon-Exec & Non-Independent Dir2026
Anil MataiIndependent Non Exe. Director2026
Hiten KotakIndependent Non Exe. Director2026
RADHIKA GUPTAIndependent Non Exe. Director2026
Vasundhara PatniNon-Exec & Non-Independent Dir2026
Yugal SikriNon-Exec & Non-Independent Dir2026
ASHOK NAIRExecutive Director & MD2026
Pratit SamdaniIndependent Non Exe. Director2026
Rajesh ShirambekarCompany Secretary / Legal Head2026
Segments — Product
SegmentRevenueShare
manufacturing and marketing of phar₹0 Cr
Segments — Geography
RegionRevenueShare
India₹483 Cr68.3%
Outside India₹224 Cr31.7%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹8151313
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-09Dividend (24/- per share)Final
dividend2026-07-09₹24 (300%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026350081760
202635000135
202600081624
Insider / Designated-Person Trades

30 recent disclosure(s)

Nucleus Life Trust RevisedAcquisition · 3,048
Nucleus Life Trust RevisedAcquisition · 4,412
Nucleus Life Trust RevisedAcquisition · 306
Nucleus Life Trust RevisedAcquisition · 1,859
Nucleus Life TrustAcquisition · 1,800
Nucleus Life TrustAcquisition · 10
Company Information
Incorporated2007
ChairmanH V Goenka
AuditorS R B C & Co LLP
Investor Email[email protected]
🌐 www.rpglifesciences.com

📍 RPG House, 463 Dr Annie Besant Road Worli, Mumbai, Maharashtra, 400030

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search